Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris, Chrysovalantis Voutouri, James W. Baish, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 7, pp. 3728-3737
Open Access | Times Cited: 233

Showing 1-25 of 233 citing articles:

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad, Beth A. Helmink, Padmanee Sharma, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5309-5337
Open Access | Times Cited: 1083
Pyroptosis: a new paradigm of cell death for fighting against cancer
Yixin Tan, Quanzhu Chen, Xiaoling Li, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 358
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 313
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
Matthias Pinter, Rakesh K. Jain, Dan G. Duda
JAMA Oncology (2020) Vol. 7, Iss. 1, pp. 113-113
Open Access | Times Cited: 266
Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
Shuang Qing, Chengliang Lyu, Li Zhu, et al.
Advanced Materials (2020) Vol. 32, Iss. 47
Closed Access | Times Cited: 227
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 223
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 177
Catalytically Active CoFe2O4 Nanoflowers for Augmented Sonodynamic and Chemodynamic Combination Therapy with Elicitation of Robust Immune Response
Shiyan Fu, Ruihao Yang, Junjie Ren, et al.
ACS Nano (2021) Vol. 15, Iss. 7, pp. 11953-11969
Closed Access | Times Cited: 169
Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Raefa Abou Khouzam, Klaudia Brodaczewska, Aleksandra Filipiak-Duliban, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 154
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Matteo Rosellini, Andrea Marchetti, Veronica Mollica, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 3, pp. 133-157
Closed Access | Times Cited: 152
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Hirsch, Tanner C. Dalton, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 720-737.e5
Open Access | Times Cited: 139
Theranostic Fluorescent Probes
Amit Sharma, Peter Verwilst, Mingle Li, et al.
Chemical Reviews (2024) Vol. 124, Iss. 5, pp. 2699-2804
Open Access | Times Cited: 138
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, Robert Power, Conall Hayes, et al.
Cancer Letters (2021) Vol. 502, pp. 84-96
Open Access | Times Cited: 135
Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
Tobiloba Elebiyo, Damilare Rotimi, Ikponmwosa Owen Evbuomwan, et al.
Cancer Treatment and Research Communications (2022) Vol. 32, pp. 100620-100620
Open Access | Times Cited: 89
VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 58
Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Teng Liu, Pei Pei, Wenhao Shen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 48
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 45
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001435-e001435
Open Access | Times Cited: 112
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis
Fotios Mpekris, Myrofora Panagi, Chrysovalantis Voutouri, et al.
Advanced Science (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 88
Vascular normalisation as the stepping stone into tumour microenvironment transformation
Anette Magnussen, Ian G. Mills
British Journal of Cancer (2021) Vol. 125, Iss. 3, pp. 324-336
Open Access | Times Cited: 85
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment
Zuzana Saidak, Simon Soudet, Marine Lottin, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 923-933
Closed Access | Times Cited: 83
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Qinjun Chen, Tao Sun, Chen Jiang
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 77
Vascular disrupting agents in cancer therapy
Ryszard Smolarczyk, Justyna Czapla, Magdalena Jarosz‐Biej, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173692-173692
Closed Access | Times Cited: 75
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 70
Page 1 - Next Page

Scroll to top